Choon-wae, Kissei conclude licensing agreement on SILODOSIN

Published: 2004-03-26 06:57:00

Updated: 2004-03-26 06:57:00

Choong-wae Pharm said recently it has concluded a licensing agreement with Japanese company Kissei Pharmaceutical Co. Under this agreement, Choongwae will be able to exclusively distribute in Korea Silodosin, Kissei's proprietary ethical drug for the treatment of urinary problems associated with ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK